Egrifta Safety Issues to Discuss

Important Information for Your Healthcare Provider

Talk with your healthcare provider prior to taking this medication if you have:
  • Cancer or a history of cancer
  • Undergone pituitary gland surgery
  • Had head irradiation
  • Experienced head trauma
  • Kidney disease, such as kidney failure (renal failure)
  • Liver disease, such as hepatitis, cirrhosis, or liver failure
  • Diabetes
  • Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
Make sure to tell your healthcare provider about any other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
(Click Egrifta Warnings and Precautions to learn more, including information on who should not take the drug.)

What If I Overdose on Egrifta?

There is currently no information available about the effects of an overdose (see Egrifta Overdose for more information).

How Should Egrifta Be Stored?

Egrifta should be protected from light and kept in its original box until you are ready to use it. Nonmixed Egrifta powder must be refrigerated between 36°F and 46°F. Mixed Egrifta should be injected immediately and not stored.
The solution for mixing (Sterile Water for Injection), syringes, and needles should be stored at room temperature.

Egrifta Medication Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.